One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Antimicrobial susceptibility-guided treatment is superior to empiric therapy for Helicobacter pylori infection in children
doi : 10.1002/jpn3.70191
Bowel habits in preterm infants: Observations from the first 2 weeks of life
doi : 10.1002/jpn3.70199
Variability in stool symptoms in youth with abdominal pain-associated disorders of gut–brain interaction
doi : 10.1002/jpn3.70205
Long-term gastrointestinal outcomes in pediatric intestinal malrotation patients following operative treatment
doi : 10.1002/jpn3.70204
Topical treatment of the anal sphincter in children with functional constipation and Hirschsprung disease
doi : 10.1002/jpn3.70181
Referral to pediatric gastroenterology for chronic abdominal pain differs by patients' individual, family, and community characteristics
doi : 10.1002/jpn3.70185
Prognosis of pediatric-onset inflammatory bowel disease associated with primary sclerosing cholangitis: A population-based study
doi : 10.1002/jpn3.70176
Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review
doi : 10.1002/jpn3.70197
Real-world efficacy of ustekinumab and vedolizumab in pediatric and young adult patients with inflammatory bowel disease
doi : 10.1002/jpn3.70198
A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for pediatric use
doi : 10.1002/jpn3.70200
Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort study
doi : 10.1002/jpn3.70202
Specific phenotypes may drive an increased incidence of pediatric inflammatory bowel disease in South-Eastern Norway
doi : 10.1002/jpn3.70148
Crohn's disease exclusion diet as an add-on to antitumor necrosis factor-α therapy in children with moderate-to-severe Crohn's disease
doi : 10.1002/jpn3.70208
Digital animation as a tool to enhance informed consent when recruiting infants with biliary atresia to a clinical trial
doi : 10.1002/jpn3.70190
Coexistence of hepatitis B e antigen and antibody during antiviral treatment predicts better clinical outcomes in children
doi : 10.1002/jpn3.70196
Pediatric liver transplant outcomes: A comparative analysis of steatotic donor grafts
doi : 10.1002/jpn3.70213
Elevated interleukin-8 in pancreatic fluid of pediatric patients with exocrine pancreatic insufficiency
doi : 10.1002/jpn3.70192
Liver function tests among children with moderate acute malnutrition: A secondary analysis of a randomized trial from Burkina Faso
doi : 10.1002/jpn3.70177
Ability of triglyceride-glucose indices to predict metabolic dysfunction associated with steatotic liver disease in pediatric obesity
doi : 10.1002/jpn3.70201
Immunological effects of alpha-lactalbumin-enriched low-protein infant formula: A randomized controlled trial
doi : 10.1002/jpn3.70189
Cystatin C: A new marker of early kidney damage in paediatric patients on parenteral nutrition for intestinal failure
doi : 10.1002/jpn3.70188
Vegan diet and nutritional status in infants, children and adolescents: A position paper based on a systematic search by the ESPGHAN Nutrition Committee
doi : 10.1002/jpn3.70182
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition 2025 guidelines on the diagnosis of cyclic vomiting syndrome in children
doi : 10.1002/jpn3.70193
Diagnostic approaches for infants with cholestatic liver diseases: Position paper and perspectives of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition
doi : 10.1002/jpn3.70207
Inflammatory cloacogenic polyp in a pediatric patient: Importance of retroflexion in anorectal evaluation
doi : 10.1002/jpn3.70206
